Pacira BioSciences Inc (PCRX)

Industry Drug Manufacturers - Specialty & Generic

This stock can be held in an Investment ISA and an Investment Account

Sell

$21.00

Buy

$25.52

arrow-down$-0.09 (-0.39%)

Prices updated at 02 Apr 2026, 21:08 EDT

Prices minimum 15 mins delay

Prices in USD

Pacira Pharmaceuticals Inc is a specialty and generic drug manufacturing company. The company develops, manufactures, and commercializes pharmaceutical products for use in hospitals and ambulatory surgery centers across the United States.

NASDAQ

0.18%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Income statement

Year chevron-l-regular chevron-r-regular	2024	2025
	701m	726m
	531m	577m
	98m	33m
	13.92	4.58
	-100m	7m
	29m	123m
Sales, General and administrative	294m	369m
Interest expenses	13m	15m
Provision for income taxes	36m	10m
Operating expenses	433m	543m
Income before taxes	-63m	17m
Net income available to common shareholders	-100m	7m
	-2.15	0.16
Net interest income	3m	5m
Advertising and promotion	-	-
Net investment income, net	-	-
Realised capital gains (losses), net	-	-
Total benefits, claims and expenses	-	-
Earnings per share (diluted)	-2.15	0.16
Free cash flow per share	3.7271	2.7095
Book value/share	16.2105	17.6866
Debt equity ratio	0.550127	0.589177

Balance sheet

Year chevron-l-regular chevron-r-regular	2024	2025
Current assets	745m	548m
Current liabilities	310m	121m
Total capital	1,162m	1,065m
Total debt	639m	418m
Total equity	778m	693m
Total non current liabilities	-	-
Loans	384m	372m
Total assets	1,554m	1,265m
Total liabilities	-	-
Cash and cash equivalents	277m	159m
Common stock	46m	41m

Cash flow

Year chevron-l-regular chevron-r-regular	2024	2025
Cash at beginning of period	153m	277m
Cash dividends paid	-	-
	179m	137m
Investments (gains) losses	-83m	99m
	277m	159m
Net income	-	-
	189m	152m
	-11m	-15m

The figures shown in the tables are quoted in the currency of the stock selected.

Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.